• HOME
  • ABOUT
  • NEWS
  • CONTACT US
  • HOME
  • ABOUT
  • NEWS
  • CONTACT US
More
844-531-1834 | info@cinrx.com

© 2025 CINRx Pharma. All Rights Reserved.

Site Pages

  • HOME
  • ABOUT
  • NEWS
  • CONTACT US
  • HOME
  • ABOUT
  • NEWS
  • CONTACT US

CINRx in The News

CinDome Pharma Announces Completion of Enrollment in the envisionGI Phase 2 Study of Deudomperidone (CIN-102) for the Treatment of Idiopathic Gastroparesis

March 17, 2026
Read More

CinDome Pharma Announces Enrollment Completion in the envision3D Phase 2 Clinical Trial of Deudomperidone (CIN-102) for the Treatment of Diabetic Gastroparesis

September 3, 2025
Read More

FOLLOW US

Linkedin-in

INVESTOR INQUIRIES

CinRx INQUIRIES